You are here: Industry Insights > HIV

News List

Can Gilead Develop a Cure for HIV? biospace
March 21, 2018
Since its first emergence in the early 1980s, HIV has gone from a terminal and untreatable disease to one that can be managed more like a chronic illness. But so far a “cure” has eluded scientists.
Trogarzo approved for HIV patients with limited treatment options europeanpharmaceuticalreview
March 12, 2018
The FDA has approved Trogarzo for adult patients whose HIV infections cannot be successfully treated…
US green lights novel HIV treatment pharmatimes
March 09, 2018
US regulators have approved a new option for treating HIV, marking the first therapy with a new mode of action in a decade.
USFDA approves Taiwan, China's HIV drug biospectrumasia
March 09, 2018
Trogarzo, with its unique mechanism, is the first new HIV treatment in ten years.
FDA greenlights alternative therapy for multidrug-resistant HIV patients pharmafile
March 08, 2018
Theratechnologies has revealed that Trogarzo has received approval from the FDA as a treatment of HIV-1 in patients with multidrug-resistant infection.
Combination therapy suppresses HIV-like virus in primates europeanpharmaceuticalreview
March 08, 2018
Broadly neutralising antibody treatment may target viral reservoir in monkeys…
FDA approves new HIV treatment for patients who have limited treatment options biospace
March 07, 2018
The U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new antiretroviral drug for use in adults with HIV
Gilead investigational data gives hope for HIV eradication in humans pharmafile
March 06, 2018
Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620
Gilead's Preclinical Combo Trial Might Eradicate HIV biospace
March 06, 2018
To date, treatments for HIV/AIDS have done a remarkable job of controlling the disease, but nothing has been able to totally eradicate the presence of the AIDS virus in patients’ bodies.
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S. biospace
March 05, 2018
Global pharmaceutical company Mylan N.V. today announced that it will launch two new HIV treatments, Symfi Lo™ and Cimduo™

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page